NDC Package 65862-237-26 Ibandronate Sodium

Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
65862-237-26
Package Description:
2500 TABLET, FILM COATED in 1 BAG
Product Code:
Proprietary Name:
Ibandronate Sodium
Non-Proprietary Name:
Ibandronate Sodium
Substance Name:
Ibandronate Sodium
Usage Information:
Ibandronate is used to prevent and treat certain types of bone loss (osteoporosis). Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases after menopause, as you age, or if you take corticosteroid medications (such as prednisone) for long periods. This medication works by slowing bone loss to help maintain strong bones and reduce the risk of broken bones (fractures). Ibandronate belongs to a class of medications called bisphosphonates.
11-Digit NDC Billing Format:
65862023726
NDC to RxNorm Crosswalk:
  • RxCUI: 904932 - ibandronate sodium 150 MG Oral Tablet
  • RxCUI: 904932 - ibandronic acid 150 MG Oral Tablet
  • RxCUI: 904932 - ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Aurobindo Pharma Limited
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Sample Package:
    N/A
    FDA Application Number:
    ANDA204502
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    03-11-2016
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    65862-237-031 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACK

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 65862-237-26?

    The NDC Packaged Code 65862-237-26 is assigned to a package of 2500 tablet, film coated in 1 bag of Ibandronate Sodium, a human prescription drug labeled by Aurobindo Pharma Limited. The product's dosage form is tablet, film coated and is administered via oral form.

    Is NDC 65862-237 included in the NDC Directory?

    Yes, Ibandronate Sodium with product code 65862-237 is active and included in the NDC Directory. The product was first marketed by Aurobindo Pharma Limited on March 11, 2016 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 65862-237-26?

    The 11-digit format is 65862023726. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-265862-237-265-4-265862-0237-26